Advances in targeted and immunobased therapies for colorectal cancer in the genomic era
Targeted therapies require information on specific defective signaling pathways or mutations. Advances in genomic technologies and cell biology have led to identification of new therapeutic targets associated with signal-transduction pathways. Survival times of patients with colorectal cancer (CRC)...
Saved in:
Main Authors: | Heng, Fong Seow, Wai, Kien Yip, Fifis, Theodora |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016
|
Online Access: | http://psasir.upm.edu.my/id/eprint/54981/1/Advances%20in%20targeted%20and%20immunobased%20therapies.pdf http://psasir.upm.edu.my/id/eprint/54981/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RAS and BRAF genes as biomarkers and target for personalised colorectal cancer therapy: An update
by: Ooi, Zhuan Shern *, et al.
Published: (2022) -
Identifying common mutations in colorectal cancer using a 7-gene panel by next generation sequencing
by: Chai, Boon Lee, et al.
Published: (2019) -
COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer
by: Ryan, A R, et al.
Published: (1999) -
Gold complexes and their molecular targets in colorectal cancer
by: Raahilah, Zahir Essa, et al.
Published: (2024) -
Loss of interleukin17RA expression is associated with tumour progression in colorectal carcinoma
by: Chai, Boon Yean, et al.
Published: (2020)